Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T08:35:48.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:46:15.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the intervention type to 'Verified 2019-11 by Tianjin Medical University Second Hospital' and noted a revision to version 2.14.0, while removing the previous intervention type and revision 2.13.3.
    Difference
    3%
    Check dated 2025-01-12T18:15:04.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:48:10.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T16:18:52.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The website has added new features for data download options, including formats like CSV, JSON, and FHIR, while removing several key government health-related links.
    Difference
    14%
    Check dated 2024-11-23T04:40:39.000Z thumbnail image

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.